A STUDY TO DETERMINE CO‐RELATION BETWEEN DISEASE BURDEN, NUMBER OF CLINICAL TRIALS DONE AND SUCCESS RATES FOR GERMANY AND INDIA.
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2014, Vol 1, Issue 17
Abstract
The drugs we use to treat any condition – from an innocuous cough to a lifethreatening cancer – are the outcome of painstaking human clinical trials. These trials are the only way to credibly determine the safety and efficacy of drugs. In recent years there has been a clear shift in clinical trial sites from core developed countries like USA, European countries to developing countries like India, China, South American countries. This shift is related to challenges and opportunities like costs of trials, recruitment issues, and regulatory challenges in developed vs. developing countries. Developing countries and developed countries have their unique disease burden patterns based on various parameters like but not limited to age, health care facilities, health insurance, sanitary conditions, environmental issues, education, nutrition and GDP. Previous studies have reported that many of the important global diseases are not much explored in clinical trials and many published clinical trials have very less international health relevance. This study was aimed at finding the correlation between disease burdens, number of clinical trials done and trial success rates. We compared 2005-2010 Global Burden of Disease data for Germany, India and number of clinical trials from clinicaltrials.gov database done in the same period. Our findings indicated that there was a good correlation between the disease burden and clinical trials for Germany in 2005 and 2010. For India in 2005 there was a moderate positive correlation, 2010 data showed the improvement in India in terms of match between disease burden and clinical Trials. But careful observation of the data shows still a need for more trials on Communicable, maternal, neonatal and nutritional disorders.
Authors and Affiliations
Dnyanesh Limaye, Gerhard Fortwengel, Vaidehi Limaye
Keywords
Related Articles
- EP ID EP227869
- DOI 10.18410/jebmh/2014/315
- Views 78
- Downloads 0
A COMPREHENSIVE STUDY OF RADIOLOGICAL EVALUATION OF GLOBAL DEVELOPMENTAL DELAY USING MRI
BACKGROUND Global developmental delay can be defined as a significant impediment in two or more developmental domains. Magnetic Resonance Imaging (MRI) is one of the best modalities for evaluation of such patients. Makin...
A CLINICAL STUDY OF HORMONE RECEPTOR STATUS IN CARCINOMA BREAST
BACKGROUND The world’s most common cancer and the second main cause of cancer death among women in the United States is breast cancer. Breast cancer is the second most common cancer among women in India after carcinoma c...
APRONS- BOON OR BANE?
BACKGROUND Aprons have long been a doctor’s ornamental and symbolic professional wear when a doctor has been recognised, respected and valued as very significant person if he wore a long sleeved white coat with a stethos...
ORAL MYIASIS: A CASE REPORT
INTRODUCTION Infestation of tissues & organs of human beings & animals with fly larvae is called myiasis. This condition is well documented in skin, nose, eye, ear, vagina and rarely in oral cavity. When tissues of oral...
NEONATAL CONJUNCTIVITIS AND ITS DRUG SENSITIVITY PATTERN
BACKGROUND Neonatal conjunctivitis is eye discharge in neonates and it is a common infection in neonates in the first month of life. Worldwide, the incidence of neonatal conjunctivitis varies from 1% to 33% depending on...